back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-05-14 11:35 Tx date 2019-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-93.94
-77 vol $1.22 each |
570 | |
| Filed 2019-05-14 11:35 Tx date 2019-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$333.06
+273 vol $1.22 each |
647 | |
| Filed 2019-05-14 11:34 Tx date 2019-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-333.06
-273 vol $1.22 each |
47,980 | |
| Filed 2018-05-11 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-340.80
-80 vol $4.26 each |
374 | |
| Filed 2018-05-11 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
-273 vol |
48,253 | |
| Filed 2018-05-11 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+273 vol |
454 | |
| Filed 2018-02-14 Tx date 2018-02-12 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
||
| Filed 2018-02-14 Tx date 2018-02-12 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
||
| Filed 2018-02-14 Tx date 2018-02-12 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
122,400 | |
| Filed 2017-05-11 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+274 vol |
274 | |
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-876.06
-93 vol $9.42 each |
181 | |
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
36 - Conversion or exchange
|
-274 vol |
48,526 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
37 - Stock split or consolidation
|
-3,282 vol |
820 | |
| Filed 2016-12-27 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+97,400 vol |
97,400 | |
| Filed 2016-12-27 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
56 - Grant of rights
|
+47,980 vol |
48,800 | |
| Filed 2016-12-27 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+4,102 vol |
4,102 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Buono, Linda
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|